Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Paul Hartmann AG

Start price
Target price
Perf. (%)
€353.00
30.06.21
€400.00
30.06.22
3.40%
10.07.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Veeva Systems A

Start price
Target price
Perf. (%)
€269.00
29.06.21
€275.00
29.06.22
-29.38%
29.06.22

Top 10 in its market
Could be worthwhile Investment >10% per year
Innovative
Some uniques
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€7.20
25.06.21
-
25.06.22
-26.39%
30.06.21

Could be very worthwhile Investment >20% year
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€413.70
18.06.21
€600.00
18.06.22
35.75%
27.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
buy
ShockWave Medical Inc

Start price
Target price
Perf. (%)
€159.00
16.06.21
€225.00
16.06.22
-5.66%
16.06.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€488.40
15.06.21
-
15.06.22
-27.06%
21.05.22

EBIT growth >5% per year expected
Very low/no dividend yield expected
buy
Spineway

Start price
Target price
Perf. (%)
€68.00
15.06.21
-
15.06.22
-52.94%
16.02.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
buy
CareCloud Inc.

Start price
Target price
Perf. (%)
€7.30
12.06.21
€8.50
12.06.22
-6.16%
10.07.21

Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
CareCloud Inc.

Start price
Target price
Perf. (%)
€7.30
12.06.21
-
12.06.22
-55.62%
12.06.22

buy
Hologic Inc.

Start price
Target price
Perf. (%)
€49.93
07.06.21
€55.00
07.06.22
42.14%
08.06.22

Could be worthwhile Investment >10% per year
buy
Abiomed Inc.

Start price
Target price
Perf. (%)
€238.80
07.06.21
€250.00
29.04.22
15.03%
30.04.22

Could be worthwhile Investment >10% per year
buy
Diasorin SpA

Start price
Target price
Perf. (%)
€142.25
06.06.21
-
06.06.22
-15.04%
07.06.22

Could be worthwhile Investment >10% per year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.30
02.06.21
-
02.06.22
9.09%
20.06.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€10.35
31.05.21
-
31.05.24
40.10%
11.03.24

Could be worthwhile Investment >10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€128.00
30.05.21
€96.00
30.05.22
-32.52%
20.12.21

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Getinge AB B

Start price
Target price
Perf. (%)
€28.89
29.05.21
€35.00
29.05.22
-6.89%
30.05.22

buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€75.60
26.05.21
€82.00
26.05.22
-36.11%
27.05.22

Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€74.55
07.05.21
€60.00
07.05.22
-37.42%
08.05.22

Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€40.55
04.05.21
€55.00
04.05.22
-11.84%
05.05.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Undervalued
buy
Ensign Group Inc.

Start price
Target price
Perf. (%)
€71.50
03.05.21
€78.00
03.05.22
2.80%
04.05.22

Could be worthwhile Investment >10% per year
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€81.20
03.05.21
€75.00
03.05.22
-41.82%
04.05.22

Could be worthwhile Investment >10% per year
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€23.00
02.05.21
-
02.05.22
-82.60%
03.05.22

Could be worthwhile Investment >10% per year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.70
02.05.21
-
02.05.22
1.08%
16.05.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Humana Inc.

Start price
Target price
Perf. (%)
€370.00
01.05.21
-
01.05.22
-5.65%
02.09.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
buy
Centene Corp.

Start price
Target price
Perf. (%)
€51.00
01.05.21
€56.00
01.05.22
50.31%
02.05.22

Could be worthwhile Investment >10% per year